James A Bourgeois, O.D., M.D.

Portrait of James A Bourgeois

Position Title
Professor and Vice-Chair of Clinical Psychiatry

Bio

James previously served as Faculty Psychiatrist and Director, Inpatient Mental Health Services, Department of Psychiatry, 60th Medical Group/David Grant Medical Center (DGMC) (Uniformed Services University of the Health Sciences and University of California, Davis School of Medicine affiliated); Faculty Psychiatrist and Chair, Department of Psychiatry, 59th Medical Wing/Wilford Hall Medical Center (WHMC) (Uniformed Services University of the Health Sciences and University of Texas Health Sciences Center at San Antonio affiliated), Faculty Psychiatrist and Director, Psychosomatic Medicine Division, Department of Psychiatry and Behavioral Sciences, University of California, Davis Medical Center (UCDMC); Faculty Psychiatrist, Consultation-Liaison Service, Vice Chair, Education and Department Education Coordinator, Department of Psychiatry & Behavioural Neurosciences, Faculty of Medicine, Michael G. DeGroote School of Medicine, McMaster University; Faculty Psychiatrist, Psychosomatic Medicine Division and Vice Chair, Clinical Affairs, Department of Psychiatry, Langley Porter Psychiatric Institute (LPPI), UCSF Weill Institute for Neurosciences, University of California, San Francisco Medical Center (UCSFMC); and Faculty Psychiatrist and Chair, Department of Psychiatry, Baylor Scott & White Health, Central Texas Division (BSWH CTD) (Texas A&M University School of Medicine and Baylor College of Medicine affiliated).

He has published 164 articles, 50 letters to the editor, 13 books-authored, 15 books-edited, and 149 book chapters/other publications. He is a Fellow and 2021 Hackett Awardee of the Academy of Consultation-Liaison Psychiatry and Distinguished Life Fellow of the American Psychiatric Association. He has been actively involved in QI, clinical management, and process improvements at all academic assignments. He also holds an MPA (health care administration focus) from Auburn University.

I have an interest in neuromodulation for treatment-resistant depressive disorder to treat patients who are non-responders to routine medication and other interventions